U.S. market Open. Closes in 6 hours 7 minutes

AUGX | Augmedix, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue44.85M30.93M22.16M16.48M14.11M
Cost of Revenue23.33M16.98M12.16M9.69M9.43M
Gross Profit21.53M13.95M10.01M6.79M4.68M
Operating Expenses40.30M36.33M27.95M20.49M21.42M
Selling, General & Admin29.13M26.18M21.27M15.96M14.44M
Research & Development11.18M10.15M6.68M4.52M6.98M
Other Operating Expenses1.00M-2.08M87.00K-1.91M1.05M
Operating Income-18.78M-22.37M-17.94M-13.69M-16.74M
Other Expenses / Income-247.00K-2.08M87.00K-1.91M-1.76M
Before Tax Income-19.03M-24.45M-17.85M-15.60M-18.50M
Income Tax Expenses145.00K2.08M-691.00K-867.00K3.86M
Net Income-19.17M-26.53M-17.16M-14.74M-22.36M
Interest Expenses2.25M2.08M2.50M1.45M2.81M
Basic Shares Outstanding43.95M37.42M28.91M7.03M831.59K
Diluted Shares Outstanding43.95M37.42M28.91M7.03M831.59K
EBITDA-17.68M-22.37M-17.94M-13.69M-14.74M
EBITDA Margin-39.42%-72.32%-80.93%-83.07%-104.46%
EBIT-16.77M-22.37M-15.35M-14.15M-15.69M
EBIT Margin-37.39%-72.32%-69.27%-85.85%-111.19%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙